Showing results (1241-1250 of 1,502) with videos related to

Sort By:
Pageof 151
Oncogene|September 8, 2009
Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathwayA C Hoover, G L Strand, P N Nowicki, et al.
Blood|May 17, 2003
Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patientsMarcel W Bekkenk, Maarten H Vermeer, Patty M Jansen, et al.
Rheumatology (Oxford, England)|February 4, 2012
The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterionMarloes Vermeer, Hillechiena H Kuper, Arie E van der Bijl, et al.
Analytica Chimica Acta|October 22, 2013
Merits of random forests emerge in evaluation of chemometric classifiers by external validationI M Scott, W Lin, M Liakata, et al.
Mbio|May 5, 2016
Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14Louis Cicchini, Joseph A Westrich, Tao Xu, et al.
Experimental Brain Research|November 16, 2018
Abnormal eyeblink conditioning is an early marker of cerebellar dysfunction in preclinical SCA3 mutation carriersJ van Gaalen, R P P W M Maas, E F Ippel, et al.
Journal of Neuromuscular Diseases|December 19, 2025
Temperature-induced symptoms in adolescents and adults with spinal muscular atrophyLeandra Aa Ros, Lina M Vermeer, Boudewijn Thm Sleutjes, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2021
Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasisLaura Ducimetière, Giulia Lucchiari, Gioana Litscher, et al.
The American Journal of Cardiology|January 1, 1988
Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatmentA van der Laarse, P L Kerkhof, F Vermeer, et al.
British Heart Journal|May 1, 1988
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The NetherlandsF Vermeer, M L Simoons, C de Zwaan, et al.
Pageof 151